Accession |
PRJCA014322 |
Title |
Exploratory study of SHR1701 combined with Famitinib in the treatment of advanced pancreatic cancer and biliary tract tumors |
Relevance |
Medical |
Data types |
Genomics data,etc
|
Organisms |
Homo sapiens
|
Description |
To evaluate the efficacy and safety of SR-1701 combined with Famitinib in the treatment of advanced pancreatic cancer and biliary tract tumors. |
Sample scope |
Multiisolate |
Release date |
2023-01-09 |
Grants |
Agency |
program |
Grant ID |
Grant title |
NA
|
|
NA
|
|
|
Submitter |
luchongyang
chongyang
lu (chongyang.lu@hengrui.com)
|
Organization |
Jiangsu Hengrui Pharmaceutical Co. LTD |
Submission date |
2023-01-09 |